155 related articles for article (PubMed ID: 34565210)
1. Anti-TRIM21 antibody is associated with aberrant B-cell function and type I interferon production in systemic lupus erythematosus.
Kunishita Y; Yoshimi R; Kamiyama R; Kishimoto D; Komiya T; Sakurai N; Sugiyama Y; Takase-Minegishi K; Kirino Y; Nagaoka S; Nakajima H
Lupus; 2021 Nov; 30(13):2054-2065. PubMed ID: 34565210
[TBL] [Abstract][Full Text] [Related]
2. TRIM21 Dysfunction Enhances Aberrant B-Cell Differentiation in Autoimmune Pathogenesis.
Kunishita Y; Yoshimi R; Kamiyama R; Kishimoto D; Yoshida K; Hashimoto E; Komiya T; Sakurai N; Sugiyama Y; Kirino Y; Ozato K; Nakajima H
Front Immunol; 2020; 11():98. PubMed ID: 32117252
[TBL] [Abstract][Full Text] [Related]
3. Dysfunction of TRIM21 in interferon signature of systemic lupus erythematosus.
Kamiyama R; Yoshimi R; Takeno M; Iribe Y; Tsukahara T; Kishimoto D; Kunishita Y; Sugiyama Y; Tsuchida N; Nakano H; Minegishi K; Tamura M; Asami Y; Kirino Y; Ishigatsubo Y; Ozato K; Nakajima H
Mod Rheumatol; 2018 Nov; 28(6):993-1003. PubMed ID: 29385873
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of circulating anti-N-methyl-
Tay SH; Fairhurst AM; Mak A
Autoimmun Rev; 2017 Feb; 16(2):114-122. PubMed ID: 27988431
[TBL] [Abstract][Full Text] [Related]
5. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
Ampélas JF; Wattiaux MJ; Van Amerongen AP
Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
[TBL] [Abstract][Full Text] [Related]
6. The Sjögren's syndrome-associated autoantigen Ro52/TRIM21 modulates follicular B cell homeostasis and immunoglobulin production.
Brauner S; Ivanchenko M; Thorlacius GE; Ambrosi A; Wahren-Herlenius M
Clin Exp Immunol; 2018 Dec; 194(3):315-326. PubMed ID: 30178506
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 3 stimulation promotes Ro52/TRIM21 synthesis and nuclear redistribution in salivary gland epithelial cells, partially via type I interferon pathway.
Kyriakidis NC; Kapsogeorgou EK; Gourzi VC; Konsta OD; Baltatzis GE; Tzioufas AG
Clin Exp Immunol; 2014 Dec; 178(3):548-60. PubMed ID: 25098814
[TBL] [Abstract][Full Text] [Related]
8. Autoantigen TRIM21/Ro52 as a Possible Target for Treatment of Systemic Lupus Erythematosus.
Yoshimi R; Ishigatsubo Y; Ozato K
Int J Rheumatol; 2012; 2012():718237. PubMed ID: 22701487
[TBL] [Abstract][Full Text] [Related]
9. Anti-Ro52/TRIM21 antibodies are associated with aberrant inflammatory circuits in patients with systemic autoimmune rheumatic diseases.
Amezcua-Guerra LM; Pérez-García LF; Jiménez-Rojas V; Márquez-Velasco R; Silveira LH
Gac Med Mex; 2023; 159(1):55-64. PubMed ID: 36930561
[TBL] [Abstract][Full Text] [Related]
10. Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology-Classified Systemic Lupus Erythematosus.
Ramsey-Goldman R; Alexander RV; Massarotti EM; Wallace DJ; Narain S; Arriens C; Collins CE; Saxena A; Putterman C; Kalunian KC; O'Malley T; Dervieux T; Weinstein A
Arthritis Rheumatol; 2020 Jan; 72(1):78-88. PubMed ID: 31469249
[TBL] [Abstract][Full Text] [Related]
11. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of usefulness of Polycheck method in the detection autoantibodies in patients with systemic lupus erythematosus, Sjögren's syndrome and systemic sclerosis].
Dryglewskal M; Majdan M; Koszarny A; Grytal A; Grzywnowicz M
Wiad Lek; 2015; 68(3):252-8. PubMed ID: 26753209
[TBL] [Abstract][Full Text] [Related]
13. Ro52/TRIM21 - From host defense to autoimmunity.
Holwek E; Opinc-Rosiak A; Sarnik J; Makowska J
Cell Immunol; 2023; 393-394():104776. PubMed ID: 37857191
[TBL] [Abstract][Full Text] [Related]
14. Serum type I interferon activity is dependent on maternal diagnosis in anti-SSA/Ro-positive mothers of children with neonatal lupus.
Niewold TB; Rivera TL; Buyon JP; Crow MK
Arthritis Rheum; 2008 Feb; 58(2):541-6. PubMed ID: 18240214
[TBL] [Abstract][Full Text] [Related]
15. Can B cell epitopes of 60 kDa Ro distinguish systemic lupus erythematosus from Sjögren's syndrome?
Scofield AN; Kurien BT; Gordon TP; Scofield RH
Lupus; 2001; 10(8):547-53. PubMed ID: 11530996
[TBL] [Abstract][Full Text] [Related]
16. The interconnected roles of TRIM21/Ro52 in systemic lupus erythematosus, primary Sjögren's syndrome, cancers, and cancer metabolism.
Hsu CH; Yu YL
Cancer Cell Int; 2023 Nov; 23(1):289. PubMed ID: 37993883
[TBL] [Abstract][Full Text] [Related]
17. SS-A/Ro antibodies in Chinese patients with systemic lupus erythematosus and Sjögren's syndrome.
Tsay GJ; Wang CL; Chen TY; Huang CN; Hsu TC
J Formos Med Assoc; 1996 Dec; 95(12):905-10. PubMed ID: 9000806
[TBL] [Abstract][Full Text] [Related]
18. Anti-proteasome activator 28alpha is a novel anti-cytoplasmic antibody in patients with systemic lupus erythematosus and Sjögren's syndrome.
Matsushita M; Matsudaira R; Ikeda K; Nawata M; Tamura N; Takasaki Y
Mod Rheumatol; 2009; 19(6):622-8. PubMed ID: 19688289
[TBL] [Abstract][Full Text] [Related]
19. Distinct Functions of Autoantibodies Against Interferon in Systemic Lupus Erythematosus: A Comprehensive Analysis of Anticytokine Autoantibodies in Common Rheumatic Diseases.
Gupta S; Tatouli IP; Rosen LB; Hasni S; Alevizos I; Manna ZG; Rivera J; Jiang C; Siegel RM; Holland SM; Moutsopoulos HM; Browne SK
Arthritis Rheumatol; 2016 Jul; 68(7):1677-87. PubMed ID: 26815287
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cell activity in Sjögren's syndrome and systemic lupus erythematosus: stimulation with interferons and interleukin-2 and correlation with immune complexes.
Struyf NJ; Snoeck HW; Bridts CH; De Clerck LS; Stevens WJ
Ann Rheum Dis; 1990 Sep; 49(9):690-3. PubMed ID: 1700674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
